The efficacy of tixagevimab/cilgavimab (Evusheld) in prophylaxis and treatment of COVID-19 in immunocompromised patients: a systematic review and meta-analysis
S Glhoom, A Fergany, D El-Araby… - European Journal of …, 2024 - Springer
Background During the COVID-19 pandemic, some populations, including
immunocompromised patients, could not tolerate COVID-19 vaccination or had low …
immunocompromised patients, could not tolerate COVID-19 vaccination or had low …
Clinical development of SpikoGen®, an Advax-CpG55. 2 adjuvanted recombinant spike protein vaccine
N Petrovsky - Human Vaccines & Immunotherapeutics, 2024 - Taylor & Francis
Recombinant protein vaccines represent a well-established, reliable and safe approach for
pandemic vaccination. SpikoGen® is a recombinant spike protein trimer manufactured in …
pandemic vaccination. SpikoGen® is a recombinant spike protein trimer manufactured in …
Epidemiological characteristics of respiratory syncytial virus infection in pediatric patients before, during the COVID‐19 pandemic and after easing of COVID‐19 …
L Hu, Y Yang, J Lin, Q Yan, C Sun, Z Li… - Journal of Medical …, 2024 - Wiley Online Library
We aimed to assess the epidemiological characteristics of respiratory syncytial virus (RSV)
infection in Chinese children at different phases of the coronavirus disease 2019 (COVID …
infection in Chinese children at different phases of the coronavirus disease 2019 (COVID …
COVID-19 vaccination and the risk of autoimmune diseases: a Mendelian randomization study
J Shan, X Hu, T Chen, Y Wang, B Huang… - Frontiers in Public …, 2024 - frontiersin.org
Background In recent times, reports have emerged suggesting that a variety of autoimmune
disorders may arise after the coronavirus disease 2019 (COVID-19) vaccination. However …
disorders may arise after the coronavirus disease 2019 (COVID-19) vaccination. However …
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
The rapid emergence of multiple strains of Severe Acute Respiratory Syndrome Coronavirus-
2 (SARS-CoV-2) has sparked profound concerns regarding the ongoing evolution of the …
2 (SARS-CoV-2) has sparked profound concerns regarding the ongoing evolution of the …
The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice
K Xu, J Li, X Lu, X Ge, K Wang, J Wang, Z Qiao, Y Quan… - Vaccines, 2024 - mdpi.com
The continuous evolution and mutation of SARS-CoV-2 have highlighted the need for more
effective vaccines. In this study, CpG, MF59-like, and Alum adjuvant Delta strain inactivated …
effective vaccines. In this study, CpG, MF59-like, and Alum adjuvant Delta strain inactivated …
Broad-spectrum RNA prophylactic and therapeutic interventions for SARS-CoV-2
A Gontu - 2024 - etda.libraries.psu.edu
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the cause of
coronavirus disease-2019 (COVID-19) pandemic is undergoing continuous evolution …
coronavirus disease-2019 (COVID-19) pandemic is undergoing continuous evolution …